STAT1 and liver cancer: Recent studies have reported that sodium butyrate, a differentiation inducer, arrested cell proliferation and strengthened the anti-tumor efficacy of IFN-α in liver cancer by specifically activating STAT1 and enhancing IFN-α-mediated STAT1 expression [162].